Pilot Trial for Implementation of a Medroxyprogesterone(MPA)Pharmacokinetic(PK) Monitoring Strategy in Patients on Mycophenolate Mofetil(MMF)/FK Based Immunosuppression.
Phase of Trial: Phase 0
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 19 Jun 2012 Primary outcome amended as reported by ClinicalTrials.gov.
- 19 Jun 2012 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Actual patient number is 22 according to ClinicalTrials.gov.